| Titolo |
Pubblicato in |
Anno |
| Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome |
SCIENTIFIC REPORTS |
2022 |
| Late-Onset MS: Disease Course and Safety-Efficacy of DMTS |
FRONTIERS IN NEUROLOGY |
2022 |
| Mait cells and microbiota in multiple sclerosis and other autoimmune diseases |
MICROORGANISMS |
2021 |
| A case of double standard. Sex differences in multiple sclerosis risk factors |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2021 |
| Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate |
FRONTIERS IN NEUROLOGY |
2021 |
| Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? |
FRONTIERS IN IMMUNOLOGY |
2021 |
| Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies |
EBIOMEDICINE |
2021 |
| Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies |
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS |
2020 |
| SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets |
F1000RESEARCH |
2020 |
| The contribution of gut barrier changes to multiple sclerosis pathophysiology |
FRONTIERS IN IMMUNOLOGY |
2019 |
| Autoimmune encephalitis and CSF anti-glur3 antibodies in an MS patient after alemtuzumab treatment |
BRAIN SCIENCES |
2019 |
| Chapter 3 - Bacille Calmette-Guérin (BCG) Vaccine in Neuroinflammation |
The Value of BCG and TNF in Autoimmunity |
2018 |
| Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report |
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS |
2017 |
| Neuropsychological predictors of rapidly progressive Alzheimer's disease |
ACTA NEUROLOGICA SCANDINAVICA |
2015 |
| Sociodemographic and clinical changes over time of individuals evaluated for cognitive disturbances: good or bad news? |
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION |
2015 |
